10.01.25 -- N=1: Redefining Clinical Pathways For Ultra-Rare Disease Treatment

Explore 20+ new CDMO presenters in quick 20-minute sessions during Outsourced Pharma’s October Partner Week (Oct. 6-10). Sessions include Analytical Services, ADC, Large and Small Molecules, Cell and Gene Therapy, and Fill/Finish. Each session offers a quick, informative look at capabilities to help you find the best-fit partner. Registration, on-demand access, and interactive Q&A are all free. Save your spot today!

In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.

Participant payments in clinical trials have long been fraught with inconsistency, raising questions about the role of IRBs, tax implications, and fair reimbursement structures.

By designing protocols and support ecosystems that address caregiver concerns, sponsors not only improve trial outcomes but also foster trust and advocacy within family-dependent populations.

The right digital partner can unlock speed, scale, and collaboration that can transform the future of your pipeline. Uncover the six steps to help you choose the right partner for your trials.

Discover innovative strategies to boost CHO DG44 cell line productivity, as well as explore optimized expression systems that enhance yield, stability, and efficiency in protein development.

Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.